| Literature DB >> 32970194 |
Toshihiro Matsukawa1, Keito Suto2,3, Minoru Kanaya4, Koh Izumiyama4, Koichiro Minauchi3, Shota Yoshida2, Hisashi Oda2, Takuto Miyagishima2, Akio Mori4, Shuichi Ota3, Daigo Hashimoto5, Takanori Teshima5.
Abstract
Diffuse large B cell lymphoma (DLBCL) is the most common type of aggressive non-Hodgkin lymphoma. Emerging evidence indicates that poor nutritional status determined with nutritional indices such as geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and controlling nutritional status score (CONUT) was associated with poor prognosis of DLBCL. We conducted this multicenter retrospective study to validate and compare prognostic values of the three indices in 615 newly diagnosed DLBCL patients. The overall survival (OS) in patients with poor nutritional status determined with each of these nutritional indices were significantly inferior compared with that in those without nutritional risks (5-year OS in patients with GNRI < 95.7 and GNRI ≥ 95.7 were 56.4% and 83.5%, P < 0.001; PNI < 42.4 and PNI ≥ 42.4 were 56.1% and 81.0%, P < 0.001; CONUT > 4 and CONUT ≤ 4 were 53.1% and 77.1%, P < 0.001). GNRI and CONUT were independent prognostic predictors for OS (GNRI < 95.7, hazard ratio [HR] 1.83, 95% confidence interval [CI] 1.22-2.74, P = 0.0032; CONUT > 4, HR 1.53, 95% CI 1.05-2.23, P = 0.028) after multivariate analyses. Nutritional status determined with GNRI affected OS more strongly in the patients with nongerminal center B cell-like (nonGCB) DLBCL compared with that in those with GCB-type DLBCL. In conclusion, baseline poor nutritional status determined based on GNRI or CONUT was an independent risk factor of newly diagnosed DLBCL, and GNRI was also useful as an independent prognostic factor for patients with nonGCB-type DLBCL.Entities:
Keywords: Controlling nutritional status score; Diffuse large B cell lymphoma; Geriatric nutritional risk index; Nutrition; Prognostic nutritional index
Mesh:
Year: 2020 PMID: 32970194 DOI: 10.1007/s00277-020-04262-5
Source DB: PubMed Journal: Ann Hematol ISSN: 0939-5555 Impact factor: 3.673